Fluimucil - Fluimucil has been shown to reduce the extent of liver injury following acetaminophen overdose. It is most effective when given early, with benefit seen principally in patients treated within 8-10 hours of the overdose. Fluimucil likely protects the liver by maintaining or restoring the glutathione levels, or by acting as an alternate substrate for conjugation with, and thus detoxification of, the reactive metabolite.
Indication: Used mainly as a mucolytic and in the management of paracetamol (acetaminophen) overdose.
Fluimucil is an antioxidant drug used to reduce the thickness of mucus and ease its removal. It is also used to reverse the toxicity of high doses of acetaminophen. Fluimucil with hydration significantly reduces the risk of contrast nephropathy in patients with chronic renal insufficiency. Also called N-acetyl-L-cysteine.
Adjuvant treatment in certain clinical conditions characterized by the presence of thick and viscous mucoid or mucopurulent secretions eg, chronic bronchopulmonary disease (chronic obstructive pulmonary disease emphysema with bronchitis, chronic asthmatic bronchitis, bronchiectasis); acute bronchopulmonary disease (asthma with bronchial mucous plugging, bronchitis, bronchopneumonia, bronchiolitis, pulmonary complications associated with surgery). Internal Medicine and Lung Diseases: All forms of bronchitis, emphysema, bronchiectasis, as well as preparatory steps for bronchography, bronchoscopy and spirometry. Ear-Nose-Throat Diseases: Inflammations associated with excessive mucus production in the ENT region, especially sinusitis, pharyngitis, otitis media and obstructive complications after tracheostomy. Diseases of Childhood: All forms of bronchitis, as well as cystic fibrosis. Surgery: Prophylaxis and therapy of bronchopulmonary complications with excessive mucus production and obstruction. Ampoule: Diseases of the respiratory tract associated with excessive mucus production (eg, bronchitis, etc), as well as in cases of otitis and sinusitis.
Capsule/Granule/Dry Syrup: : As a mucolytic therapy in acute, chronic bronchial and pulmonary disease associated with thick mucous secretions eg, acute bronchitis, chronic bronchitis and acute exacerbation, pulmonary emphysema, mucoviscidosis and bronchiectasis. Ampule: Treatment of respiratory infection characterized by thick and viscous hypersecretions.
Sachet: Adjuvant treatment in certain clinical conditions characterized by the presence of thick and viscous mucoid or mucopurulent secretions, eg chronic bronchopulmonary diseases (eg, chronic obstructive pulmonary disease, emphysema with bronchitis, chronic asthmatic bronchitis and bronchiectasis); acute bronchopulmonary diseases (eg, asthma with bronchial mucus plugging, bronchitis, bronchopneumonia, tracheobronchitis, bronchiolitis, pulmonary complications of cystic fibrosis, pulmonary complications associated with surgery). Syrup: Treatment of respiratory affections characterized by thick and viscous hypersecretions, eg acute bronchitis, chronic bronchitis and its exacerbation, pulmonary emphysema, mucoviscidosis and bronchioectasis. Ampoule: Topical Use: Otorhinolaryngology: Catarrhal otitis, tubal catarrh ; mucocrustal and mucopurulent rhinitis, sinusitis, rhinopharyngitis, pharyngo laryngitis, laryngo-tracheitis; prophylaxis and treatment of obstructive and infectious complications of tracheotomy; preparation to bronchoscopy, bronchography, bronchoaspiration, etc. Medicine-Pediatrics: Acute and chronic bronchitis, asthmatic bronchitis, emphysema, long-lasting bronchopneumonia and pneumonia, pulmonary abscess, bronchiectasis, pulmonary-atelectasis, bronchiolitis, mucoviscidosis, certain forms of neonatal asphyxia, etc. Surgery: Prophylaxis and treatment of bronchopulmonary complications following surgical interventions (on thorax, abdomen, etc). Phthisiology: Bronchial catarrh associated with pulmonary tuberculosis, retention of secretion due to insufficient drainage of cavitary lesions. Systemic Use: In all cases of bronchopulmonary affections previously enumerated, when topical treatment is difficult or impossible, or when the physician considers the systemic route to be preferable (lack of cooperation on the part of the patient, bed ridden patients, respiration in closed circuit, etc).
Indications: respiratory-tract disorders associated with excess or viscous mucus
Indications: respiratory-tract congestion
Indications: respiratory-tract disorders associated with increased or viscous mucus, paracetamol overdosage, haemorrhagic cystitis, adjunct to cyclophosphamide treatment
This medicine is indicated as adjuvant therapy for patients with abnormal, viscid, or inspissated mucous secretions in such conditions as:Chronic bronchopulmonary disease (chronic emphysema, emphysema with bronchitis, chronic asthmatic bronchitis, tuberculosis, bronchiectasis and primary amyloidosis of the lung)Acute bronchopulmonary disease (pneumonia, bronchitis, tracheobronchitis)Pulmonary complications of cystic fibrosisTracheostomy carePulmonary complications associated with surgeryUse during anesthesiaPost-traumatic chest conditionsAtelectasis due to mucous obstructionDiagnostic bronchial studies (bronchograms, bronchospirometry, and bronchial wedge catheterization)